Influence of NCI Cancer Center Attendance on Mortality in Lung, Breast, Colorectal, and Prostate Cancer Patients
Reads0
Chats0
TLDR
Attendance at NCI cancer centers is associated with a significant survival benefit for the four major cancers among Medicare beneficiaries and was evident across all levels of comorbidities.Abstract:
Some evidence links cancer outcomes to place of service, but the influence of NCI (National Cancer Institute) cancer centers on outcomes has not been established. We compared mortality for NCI cancer center attendees versus nonattendees. This retrospective cohort study included individuals with incident cancers of the lung, breast, colon/rectum, or prostate from 1998 to 2002 (N = 211,084) from SEER (Surveillance, Epidemiology, and End Results)—Medicare linked data, with claims through 2003. We examined the relation of NCI cancer center attendance with 1- and 3-year all-cause and cancer-specific mortality using multilevel logistic regression models. NCI cancer center attendance was associated with a significant reduction in the odds of 1- and 3-year all-cause and cancer-specific mortality. The mortality risk reduction associated with NCI cancer center attendance was most apparent in late-stage cancers and was evident across all levels of comorbidities. Attendance at NCI cancer centers is associated with a ...read more
Citations
More filters
Journal ArticleDOI
The impact of comorbidity on cancer survival: a review
Mette Søgaard,Reimar W. Thomsen,Kristine Skovgaard Bossen,Henrik Toft Sørensen,Mette Nørgaard +4 more
TL;DR: In general, comorbidity does not appear to be associated with more aggressive types of cancer or other differences in tumor biology, and it is unclear from the literature whether the apparent undertreatment reflects appropriate consideration of greater toxicity risk, poorer clinical quality, patient preferences, or poor adherence among patients with comor bidity.
Journal ArticleDOI
A relative spatial access assessment approach for analyzing potential spatial access to colorectal cancer services in Texas
TL;DR: In this article, the authors proposed the concept of spatial access ratio (SPAR) derived from the enhanced 2-step floating catchment area (E2SFCA) method to assess potential spatial access.
Journal ArticleDOI
Impact of care at comprehensive cancer centers on outcome: Results from a population-based study.
TL;DR: To the authors' knowledge, the impact of NCICCC care on survival and access toNCICCCs for vulnerable subpopulations remain unstudied.
Journal ArticleDOI
Predictors and Intensity of Online Access to Electronic Medical Records Among Patients With Cancer
David E. Gerber,Andrew L. Laccetti,Beibei Chen,Jingsheng Yan,Jennifer Cai,Samantha Gates,Yang Xie,Simon J. Craddock Lee +7 more
TL;DR: Among patients with cancer, PHR portal use is frequent and increasing, and younger patients, white patients, and patients with upper aerodigestive malignancies exhibit the heaviest portal use.
Journal ArticleDOI
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.
E. Van Cutsem,Mario Dicato,Nadir Arber,Jordan Berlin,Andrés Cervantes,Fortunato Ciardiello,A. de Gramont,Eduardo Díaz-Rubio,Michel Ducreux,Ravit Geva,Ravit Geva,Bengt Glimelius,R. Glynne Jones,Axel Grothey,Thomas Gruenberger,Daniel G. Haller,Karin Haustermans,Roberto Labianca,Heinz-Josef Lenz,Bruce D. Minsky,Bernard Nordlinger,A. Ohtsu,N. Pavlidis,Ph. Rougier,Wolff Schmiegel,C.J.H. van de Velde,H.-J. Schmoll,Alberto Sobrero,Josep Tabernero +28 more
TL;DR: The article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC) as well as a proposed treatment decision strategy for mCRC treatment during the 11th ESMO/World Gastrointestinal Cancer Congress in Barcelona in June 2009.
References
More filters
Journal ArticleDOI
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆
TL;DR: The method of classifying comorbidity provides a simple, readily applicable and valid method of estimating risk of death fromComorbid disease for use in longitudinal studies and further work in larger populations is still required to refine the approach.
Journal ArticleDOI
Revisiting the behavioral model and access to medical care: does it matter?
TL;DR: The Behavioral Model of Health Services Use was initially developed over 25 years ago and is reviewed and assessed for continued relevance.
Journal ArticleDOI
Hospital Volume and Surgical Mortality in the United States
John D. Birkmeyer,Andrea E. Siewers,Emily Finlayson,Therese A. Stukel,F. Lee Lucas,Ida Batista,H. Gilbert Welch,David E. Wennberg +7 more
TL;DR: Mortality decreased as volume increased for all 14 types of procedures, but the relative importance of volume varied markedly according to the type of procedure.
Journal ArticleDOI
Hospital volume and surgical mortality in the United States
TL;DR: In the absence of other information about the quality of surgery at the hospitals near them, Medicare patients undergoing selected cardiovascular or cancer procedures can significantly reduce their risk of operative death by selecting a high-volume hospital.
Journal ArticleDOI
Development of a comorbidity index using physician claims data.
TL;DR: A comorbidity index that incorporates the diagnostic and procedure data contained in Medicare physician (Part B) claims and demonstrates the utility of a disease-specific index using an alternative method of construction employing study-specific weights.